(Q40012658)

16 September 2017

title

Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A183590

history and philosophy of science

25 December 2022

main subject

myasthenia gravis

0 references

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

25 December 2022

author name string

N. G. Brunner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A183590

25 December 2022

C. L. Berger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A183590

25 December 2022

T. Namba

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A183590

25 December 2022

D. Grob

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A183590

25 December 2022

language of work or name

English

0 references

publication date

1 January 1976

1 reference

full work available at URL

16 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1976.tb47717.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1976.tb47717.x/fullpdf

25 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Annals of the New York Academy of Sciences

25 December 2022

published in

1 reference

16 September 2017

volume

274

1 reference

16 September 2017

page(s)

577-595

1 reference

Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses.

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB47717.X

Studies in myasthenia gravis. Short-term massive corticotropin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB47717.X

Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB47717.X

Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB47717.X

Certain endocrine and metabolic facets of the steroid withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB47717.X

Letter: Acute arthralgia following high-dose intravenous methylprednisolone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB47717.X

Letter: Acute arthralgia after high-dose intravenous methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB47717.X

CORTICOTROPIN IN TREATMENT OF OCULAR MYASTHENIA; A CONTROLLED CLINICAL TRIAL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB47717.X

Treatment of ocular myasthenia with corticotrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB47717.X

EMG analysis of myasthenic ACTH deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB47717.X

Effects of corticosterone, hydrocortisone, and corticotropin on production of antibodies in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1976.TB47717.X

Treatment of severe myasthenia gravis with large doses of ACTH

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Corticotropin therapy in myasthenia gravis: effects, indications, and limitations

25 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Corticotropin therapy and thymectomy in management of myasthenia gravis

25 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy

25 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

The treatment of severe myasthenia gravis with immunosuppressive agents

25 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Myasthenia gravis and myasthenic syndromes treated with prednisone

25 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Continuous treatment of myasthenia gravis with prednisone

25 December 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Benefit from alternate-day prednisone in myasthenia gravis

25 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Treatment of myasthenia gravis with prednisone

25 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Adverse interaction between steroid hormones and anticholinesterase drugs

25 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

25 December 2022

Myasthenia gravis

22

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Peptic Ulcer in Myasthenia Gravis

25 December 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Ocular response to corticotropin in myasthenia gravis

25 December 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Oral corticosteroids in the treatment of ocular myasthenia gravis

25 December 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Corticotropin therapy in patients with myasthenia gravis. Electrophysiologic, pharmacologic studies

25 December 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

CORTISONE EFFECTS ON MYONEURAL JUNCTION

25 December 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

The effect of corticotropin on the neuromuscular junction. Morphologic studies in rabbits

25 December 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Corticosteroids: a direct effect at the neuromuscular junction

25 December 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Changes in serum complement activity in patients with myasthenia gravis

25 December 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Effect of serum and serum globulin of patients with myasthenia gravis on neuromuscular transmission

25 December 2022

40

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors

25 December 2022

42

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Effect on mice of intravenous administration of lymphocytes from normal subjects and from patients with myasthenia gravis

25 December 2022

47

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Lymphocytes of patients with myasthenia gravis. Local effects in rats following intramuscular administration

25 December 2022

48

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

Myasthenia gravis and acetylcholine receptor. Effect of steroids in clinical course and cellular immune response to acetylcholine receptor

25 December 2022

49

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1976.TB47717.X

25 December 2022

Identifiers

1 reference

16 September 2017

1 reference